BAXTER INTERNATIONAL INC. : Baxter and Onconova Announce European … Rigosertib is currently being evaluated in a Phase III clinical trial in 270 MDS patients who have failed or relapsed after receiving current therapeutic … See all stories on this topic ยป ********************** MORE USEFUL INFORMATION.... The LINKS below are from high authority and related…



Recent Comments